
How to Find the Truly Optimal Care Pathway for Different Cancer Patients?
Every cancer patient is unique. Two people with the same type and stage of lung cancer may have completely different driver mutations (EGFR vs. KRAS vs. no actionable alteration). One breast cancer patient may respond dramatically to conventional chemotherapy, while another achieves better results with specific natural compounds. Choosing the wrong direction not only reduces efficacy but also adds unnecessary toxicity and fatigue. This is why leading cancer centers worldwide have moved away from one-size-fits-all protocols toward genuinely individualized care.








